Advertisement

Alternate Aggregation Pathways of Alzheimer β-Amyloid Peptides

  • Paul Gorman
  • Christopher M. Yip
  • Paul E. Fraser
  • Avijit Chakrabartty
Part of the American Peptide Symposia book series (APSY, volume 7)

Abstract

Alzheimer’s Disease (AD) is a neuropathological disorder characterized by the progressive deposition in the brain of insoluble amyloid plaques and vascular deposits consisting primarily of the 4.5 kDa β-amyloid peptide (Aβ). There is increasing evidence that formation of these fibrillar deposits leads to the neurodegeneration observed in AD. Elucidating the mechanism of this polymerization process is therefore of great importance in the development of potential inhibitors. The detailed mechanism of Aβ production is still unclear, however there is increasing evidence that Aβ is initially produced through an endocytic-recycling pathway [1]. We have therefore investigated the association of Aβ at endosomal pH in an attempt to identify the initial stages of Aβ fibrillogenesis. Because individual techniques have inherent shortcomings, we employed several techniques for monitoring Aβ association, which include fluorescence resonance energy transfer (FRET), dynamic light scattering (DLS), atomic force microscopy (AFM), and electron microscopy (EM).

Keywords

Atomic Force Microscopy Dynamic Light Scattering Dynamic Light Scattering Fluorescence Resonance Energy Transfer Mica Surface 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Koo, E.H., Squazzo, S.L. J. Biol Chem. 269, 17386–17389 (1994).PubMedGoogle Scholar
  2. 2.
    Harper, J.D., et al. Biochemistry 38, 8972–8980 (1999).PubMedCrossRefGoogle Scholar
  3. 3.
    Walsh, D., et al. J. Biol Chem. 274, 25945–25952 (1999).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2001

Authors and Affiliations

  • Paul Gorman
    • 1
  • Christopher M. Yip
    • 2
  • Paul E. Fraser
    • 3
  • Avijit Chakrabartty
    • 1
  1. 1.Ontario Cancer InstituteUniversity Health Network, University of TorontoTorontoCanada
  2. 2.Department of Chemical Engineering and Applied ChemistryUniversity of TorontoTorontoCanada
  3. 3.Center for Research in Neurodegenerative DiseaseUniversity of TorontoTorontoCanada

Personalised recommendations